U.S. Hospitality Stock News

If you are wondering whether Group 1 Automotive's current share price reflects its true worth, this article walks through the numbers in a clear, practical way. The stock recently closed at US$395.06, with a 1 year return of an 11.3% decline, a 3 year return of 104.2% and a 5 year return of 161.4%, so recent moves look quite different depending on how far back you zoom. In the short term, returns over the last 7 days and 30 days, 1.9% and 3.1% declines respectively, contrast with the modest...

AIRO Group Holdings recently strengthened its balance sheet with US$83.70 million in cash and US$89.40 million in follow-on proceeds, easing near-term dilution concerns while continuing work on joint ventures, certifications and backlog conversion. What looks like routine execution, closing partnerships, securing approvals and turning backlog into revenue, could prove decisive in reshaping how the market views AIRO’s business quality. Next, we’ll examine how AIRO’s bolstered liquidity...

TSS, Inc. recently presented at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, featuring Chief Financial Officer Daniel M. Chism and CEO, President & Director Darryll E. Dewan. This conference appearance gave management a high-visibility platform to communicate TSS’s business direction and priorities directly to a concentrated investor audience. We’ll now look at how investor expectations around TSS’s Needham conference presentation may influence...

If you are wondering whether Expeditors International of Washington at US$162.41 is offering good value right now, it helps to step back and look at what the current price might be implying. The stock has posted returns of 2.2% over the last 7 days, 8.5% over 30 days, 6.9% year to date, 49.0% over 1 year and 57.7% over 3 years, with a 5 year return of 83.4%. This naturally raises questions about how much of the story is already priced in. Recent attention on Expeditors has centered on its...

Scholar Rock recently outlined its 2026 plans around potential U.S. and European approvals and commercial launch preparations for apitegromab in spinal muscular atrophy, alongside ongoing clinical trials and leadership changes to support a move toward commercialization. An interesting angle is how Scholar Rock is extending apitegromab into younger SMA populations and facioscapulohumeral muscular dystrophy while scaling manufacturing and organizational capacity to support a broader...

Triad Investment Management’s new position in Macerich (MAC), totaling 206,916 shares valued around US$3.82 million, has put fresh institutional attention on this retail REIT after a period of sector volatility. See our latest analysis for Macerich. Triad’s new position comes as Macerich’s share price, last closing at US$18.74, has recorded a 90 day share price return of 8.70%. The 3 year total shareholder return of 73.05% contrasts with a 1 year total shareholder return decline of 1.67%,...

Earlier this week, BioMarin Pharmaceutical appointed Arpit Davé as Executive Vice President, Chief Digital and Information Officer, a new C-level role reporting directly to CEO Alexander Hardy and overseeing enterprise technology, data science, and digital transformation. By bringing in a biopharma technology veteran with extensive artificial intelligence experience from Amgen, Bristol Myers Squibb, and Merck, BioMarin is signaling a stronger emphasis on data-driven decision making across...

In recent months, Green Brick Partners announced that several of its master-planned communities were ranked among the top developments nationally and in North Texas by John Burns Research and Consulting, RCLCO, and the Dallas Business Journal, while the company was recognized as the number three homebuilder in North Texas by new home closings. This cluster of independent accolades underscores Green Brick’s strong execution in key Sunbelt markets and highlights the scale of its presence in...

Why Microvast’s New Finance Leadership Matters for Investors Microvast Holdings (MVST) has refreshed its senior finance team, naming interim finance lead Rodney Worthen as Chief Financial Officer and hiring former NextDecade executive Eric N. Garcia as Chief Accounting Officer. These appointments concentrate financial reporting, planning, and corporate development experience at the top of Microvast’s battery and energy storage business, which already reports annual revenue of US$444.5 million...

In December 2025, Federal Agricultural Mortgage completed a US$313.5 million securitization of agricultural mortgage loans, signaling continued investor appetite for its farm and rural credit exposure despite recent macro volatility. This transaction highlights how the company can recycle capital from its Farm & Ranch and related portfolios to support future lending capacity across rural America. Next, we’ll explore how this securitization and improving monetary conditions could influence...

Recent financial media coverage has pushed LexinFintech Holdings (LX) into the spotlight as a penny stock candidate, with attention centering on its fundamentals and its role within consumer finance during broader market volatility. See our latest analysis for LexinFintech Holdings. Despite the recent media spotlight, LexinFintech Holdings has faced pressure, with a 90 day share price return of a 40.12% decline and a 1 year total shareholder return of a 54.17% decline, suggesting momentum has...

Spire Global (SPIR) is back in focus after the company launched nine satellites on SpaceX's Twilight mission, including its HyMS weather sensor and eight satellites supporting Myriota's global IoT connectivity network. See our latest analysis for Spire Global. That satellite launch comes on the back of a sharp swing in sentiment, with a 72.51% 30 day share price return and a 55.06% year to date share price return, even though the 1 year total shareholder return is still a 32.65% decline. If...

Curtiss-Wright (CW) recently partnered with Green Hills Software to launch a safety-certifiable COTS computing platform for aerospace and defense, raising fresh questions about how this product expansion aligns with the stock’s strong recent returns. See our latest analysis for Curtiss-Wright. The Green Hills collaboration arrives during a strong run for Curtiss-Wright, with a 24.41% 30-day share price return and a 21.77% 90-day share price return. The 1-year total shareholder return of...

Earlier this month, FuelCell Energy ended the employment of its Executive Vice President, General Counsel and Corporate Secretary Joshua Dolger without cause, and appointed Amanda J. Schreiber to those roles effective January 12, 2026. Schreiber’s extensive experience guiding complex power projects, governance, and risk management at ContourGlobal brings a power-sector-focused legal and compliance perspective to FuelCell Energy’s leadership team. Next, we’ll examine how Schreiber’s...

Latest Earnings Snapshot and How It Fits the Story Regions Financial (RF) has wrapped up FY 2025 with fourth quarter revenue of US$1,806 million and EPS of US$0.59, alongside trailing 12 month revenue of US$7.1 billion and EPS of US$2.31 that frame the full year picture. Over recent quarters the company has seen revenue move from US$1,660 million in Q1 2025 to US$1,811 million in Q3 2025, and EPS range between US$0.51 and US$0.62. This gives investors a clear line of sight on how the top line...

If you are wondering whether Ziff Davis is a bargain or a value trap at its current US$37.48 share price, you are not alone. The stock has returned 3.6% over the last 7 days and 4.8% over the last 30 days. Year to date it is at 10.3%, with a 31.8% decline over 1 year and a 56.1% decline over 3 years. These mixed returns sit against an ongoing stream of corporate updates and portfolio activity that continue to keep Ziff Davis on investors' watchlists. Together, these developments help explain...

Conference spotlight and why investors are watching LightPath Technologies (LPTH) is set to present at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, and that upcoming appearance is drawing fresh attention from investors. See our latest analysis for LightPath Technologies. That conference appearance comes after a sharp run in the shares, with a 30 day share price return of 82.70% and a 1 year total shareholder return of 273.00%. This suggests...

Why EVERTEC (EVTC) is on investors’ radar today EVERTEC (EVTC) has drawn investor attention after its latest financial metrics highlighted solid transaction processing activity across Latin America and the Caribbean, with annual revenue of US$903.381m and net income of US$146.091m. Those headline figures, combined with mixed recent share returns and an assigned value score of 5, are prompting investors to reassess how this regional payments and fintech provider fits into a diversified...

If you are wondering whether AdaptHealth's share price lines up with its underlying worth, you are not alone. This article focuses squarely on what the current price might be implying about value. The stock last closed at US$10.61, with returns of 1.1% over 7 days, 1.2% over 30 days, 9.7% year to date and 0.9% over 1 year. These figures are set against much weaker 3 year and 5 year returns of 49.5% and 72.1% declines. Recent coverage has focused on AdaptHealth's position in the home...

If you are wondering whether W.W. Grainger at around US$1,068.72 is priced for strength or stretched, you are not alone. This article is built to help you frame that question clearly. The stock has returned 3.8% over the last 7 days, 4.8% over the last 30 days, 6.5% year to date, but shows a 3.2% decline over the last year, while longer periods such as 3 years and 5 years sit at 96.0% and 187.0% respectively. Recent coverage of W.W. Grainger has centered on its role as a key industrial...

Why Marqeta’s New CFO Matters for Investors Marqeta (MQ) has appointed Patti Kangwankij as Chief Financial Officer, effective February 9, 2026. This leadership change puts an experienced technology and payments executive at the center of its financial decision making. See our latest analysis for Marqeta. Despite the CFO appointment setting a fresh tone for execution, Marqeta’s recent 30 day share price return of 9.35% and year to date share price return of 3.88% are weaker, while the 1 year...

BlackRock (BLK) has wrapped up FY 2025 with fourth quarter revenue of US$7.0b and basic EPS of US$7.26, while trailing 12 month figures show revenue of US$24.2b and EPS of US$35.83. Over recent periods, revenue has moved from US$20.4b in the trailing 12 months to Q4 2024 to US$24.2b by Q4 2025, with basic EPS shifting from US$42.45 to US$35.83 over the same comparison window. With trailing net profit margin at 22.9%, down from 31.2% a year earlier, the latest results pair solid top line...

If you are wondering whether Somnigroup International at around US$94 is priced for perfection or still offers value, this breakdown will help you frame that question clearly. The share price comes with a 0.2% return over the last 7 days, 5.6% over 30 days, 5.9% year to date and 59.0% over the past year, with a 3 year return of 152.1% and 5 year return of 243.0% that many investors will want to put into context. Recent coverage has focused on Somnigroup International's position within its...

Why Compass Therapeutics Is On Investors’ Radar Compass Therapeutics (CMPX) has drawn attention after recent share price moves, with the stock showing double digit returns over the past month and past 3 months despite reporting a net loss and no revenue. See our latest analysis for Compass Therapeutics. At a share price of $5.70, Compass Therapeutics has a 30 day share price return of 14.92% and a 90 day share price return of 33.80%. Its 1 year total shareholder return of 119.23% suggests...